US Patent 11839689 Formulations of enzalutamide

Is a

Patent

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

118396890

Patent Inventor Names

Toshiro Sakai0

Koji Nishimura0

Jason A. Everett0

Douglas Alan Lorenz0

Sanjay Konagurthu0

Hiroyasu Toyota0

Shinsuke Oba0

Yuuki Takaishi0

...

Date of Patent

December 12, 2023

Patent Application Number

179852350

Date Filed

November 11, 2022

Patent Citations

‌

US Patent 7709517 Diarylhydantoin compounds

‌

US Patent 8183274 Treatment of hyperproliferative disorders with diarylhydantoin compounds

‌

US Patent 7780988 Method for making homogeneous spray-dried solid amorphous drug dispersions using pressure nozzles

‌

US Patent 8445507 Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases

‌

US Patent 6899899 Rapidly disintegrable pharmaceutical composition

‌

US Patent 7189415 Rapidly disintegrable pharmaceutical composition

Patent Primary Examiner

CPC Code

Patent abstract

This disclosure provides formulations of enzalutamide and their use for treating hyperproliferative disorders.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

US Patent 11839689 Formulations of enzalutamide

Contents

Patent attributes

Timeline

Further Resources

References

Find more entities like US Patent 11839689 Formulations of enzalutamide